A robust design for identification of the Parasite Clearance Estimator

by Kris M. Jamsen, Stephen B. Duffull, Joel Tarning, Ric N. Price, Julie A. Simpson
Published 2018

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria

by Kris M. Jamsen, Stephen B. Duffull, Joel Tarning, Niklas Lindegardh, Nicholas White, Julie A. Simpson
Published 2018

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria

by Kris M. Jamsen, Stephen B. Duffull, Joel Tarning, Niklas Lindegardh, Nicholas J. White, Julie A. Simpson
Published 2018

Towards optimal design of anti-malarial pharmacokinetic studies

by Julie A. Simpson, Kris M. Jamsen, Ric N. Price, Nicholas J. White, Niklas Lindegardh, Joel Tarning, Stephen B. Duffull
Published 2018

Phase I and Pharmacokinetic Study of 10-Propargyl-10-Deazaaminopterin, a New Antifolate

by Krug, L., Kris, M., Miller, V., Tong, W., Heelan, R., Leon, L., Leung, Denis H. Y., Kelly, J., Grant, S., Sirotnak, F.
Published 2000

Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum

by Julie A. Simpson, Kris M. Jamsen, Tim J.C. Anderson, Sophie Zaloumis, Shalini Nair, Charles Woodrow, Nicholas J. White, Francois Nosten, Ric N. Price
Published 2018

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

by Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
Published 2011